Latest Precigen News & Updates

See the latest news and media coverage for Precigen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Precigen

Commercial-stage biopharmaceutical company focused on precision medicines

precigen.com

Headquarters: Germantown, United States
Founded year: 2020
Company type: Public company
Number of employees: 150–200
Industry: Pharmaceuticals

Last updated Today

Latest news about Precigen

In short: Precigen achieved full FDA approval and market exclusivity for PAPZIMEOS, the first therapy for adults with recurrent respiratory papillomatosis.

Company announcements

July 21 Precigen

Precigen to report Q2 2026 financial results and updates

The company will host a conference call on August 4, 2026 at 4:30 PM ET to discuss.

May 30 Precigen

Precigen presents new long-term durability data for PAPZIMEOS

83% of complete responders maintained response for at least 36 months, with five beyond four years, and the drug received seven-year market exclusivity.

May 27 Precigen

Precigen will present pivotal trial data at symposium

The data shows complete responses and reduced surgical debulking in recurrent respiratory papillomatosis patients.

May 27 Precigen

Precigen receives orphan drug exclusivity for PAPZIMEOS

The FDA granted seven-year market exclusivity for the RRP treatment, effective through August 2032.

Media coverage

July 27 Stockhouse

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

- EU Orphan Drug Designation is the first regulatory designation for a gorilla adenovector based immunotherapy outside of the United States for the Company ...

July 21 Yahoo Finance

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the...

July 15 The Globe and Mail

What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?

CFO Harry Thomasian Jr. sold 200,000 shares of Precigen common stock across two transactions for a total value of approximately $1.11 million, based on a...

June 23 Yahoo Finance

Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason

Precigen Inc. (NASDAQ:PGEN) is one of the 10 Stocks Paying Off Big Time. Precigen rallied for a second day on Monday, surging 11.62 percent to...

Never miss news about Precigen

Track Precigen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Precigen competitors & trending companies

Browse news for competitors to Precigen and other trending companies.